MedTrace Logo

Long-term Pulmonary Outcomes After Infection With Sars-CoV-2

NCT04401163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 218

Last updated 2023-05-12

No results posted yet for this study

Summary

The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.

Conditions

  • Sars-CoV2
  • Covid19

Interventions

DIAGNOSTIC_TEST

Imaging of the lungs

After hospital admissions with COVID19 patients will come for two clinical visits to complete a number of questionnaires, pulmonary function testing, six-minute walk test, blood sampling and imaging of the lungs.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Elisabeth Bendstrup, MD, PhD · Aarhus University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-18
Primary Completion
2021-10-01
Completion
2022-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04401163 on ClinicalTrials.gov